agilon health (NYSE:AGL) Trading Down 6.3% - Here's What Happened

agilon health, inc. (NYSE:AGL - Get Free Report)'s stock price was down 6.3% during trading on Tuesday . The company traded as low as $2.53 and last traded at $2.53. Approximately 1,200,620 shares were traded during trading, a decline of 75% from the average daily volume of 4,899,374 shares. The stock had previously closed at $2.70.

Analyst Ratings Changes

A number of equities research analysts recently commented on AGL shares. Royal Bank of Canada restated an "outperform" rating and set a $8.00 price objective on shares of agilon health in a report on Wednesday, August 7th. Bank of America lowered shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a report on Friday, August 9th. Citigroup restated a "sell" rating and set a $2.50 price objective (down from $7.00) on shares of agilon health in a report on Tuesday. Finally, Evercore ISI dropped their price objective on shares of agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a report on Tuesday, October 8th. Three analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, agilon health has a consensus rating of "Hold" and a consensus price target of $7.81.

agilon health Trading Down 6.7 %

The business's 50-day moving average price is $3.54 and its 200 day moving average price is $5.11. The company has a market cap of $1.04 billion, a P/E ratio of -3.60 and a beta of 0.54. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, meeting analysts' consensus estimates of ($0.07). agilon health had a negative net margin of 5.57% and a negative return on equity of 29.91%. The company had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the firm posted ($0.04) EPS. The company's quarterly revenue was up 38.7% on a year-over-year basis. As a group, analysts expect that agilon health, inc. will post -0.32 earnings per share for the current year.

Insider Activity

In related news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company's stock, valued at approximately $227,102.40. This represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.20% of the company's stock.

Hedge Funds Weigh In On agilon health

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of agilon health by 1.3% in the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company's stock valued at $176,582,000 after buying an additional 371,537 shares in the last quarter. Capital International Investors increased its position in agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company's stock worth $123,207,000 after purchasing an additional 9,263,296 shares in the last quarter. AQR Capital Management LLC increased its position in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock worth $8,871,000 after purchasing an additional 1,316,990 shares in the last quarter. Bank of New York Mellon Corp increased its position in agilon health by 18.7% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company's stock worth $7,252,000 after purchasing an additional 174,883 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC increased its position in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock worth $5,262,000 after purchasing an additional 316,856 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.